<H1>Chapter DOI: 10.1186/s12944-016-0273-9<br/>Cited-By Count: 0</H1><table border="1" width="30%"><tr><td>Total References</td><td>36</td></tr><tr><td>Springer references</td><td>4</td></tr><tr><td>Non Springer references</td><td>32</td></tr><tr><td>BibStructured Count</td><td width="10%">36</td></tr><tr><td>BibUnstructured Count</td><td width="10%">0</td></tr><tr><td>DOI already available in SpringerLink</td><td>34</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>2</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>0</td></tr><tr><td>DOI Obtained For Non Springer</td><td>2</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>2</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>0</td></tr><tr><td>Valid DOI Enriched</td><td>1</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibArticle</td><td>Van den Brink DM, Wanders RJ. Phytanic acid: production from phytol, its breakdown and role in human disease. Cell Mol Life Sci. 2006;63:1752&#8211;65.</td><td><a href=http://dx.doi.org/10.1007/s00018-005-5463-y>10.1007/s00018-005-5463-y</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR2</td><td>BibArticle</td><td>Wanders RJ, Komen J, Ferdinandusse S. Phytanic acid metabolism in health and disease. Biochim Biophys Acta. 1811;2011:498&#8211;507.</td><td><a href=http://dx.doi.org/10.1016/j.bbalip.2011.06.006>10.1016/j.bbalip.2011.06.006</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_2, ArticleTitle, FirstPage, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR3</td><td>BibArticle</td><td>Hellgren LI. Phytanic acid-an overlooked fatty acid in dairy fat? Ann N Y Acad Sci. 2010;1190:42&#8211;9.</td><td><a href=http://dx.doi.org/10.1111/j.1749-6632.2009.05254.x>10.1111/j.1749-6632.2009.05254.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR4</td><td>BibArticle</td><td>Wierzbicki AS. Peroxisomal disorders affecting phytanic acid alph-oxidation: a review. Biochem Soc Trans. 2007;35:881&#8211;6.</td><td><a href=http://dx.doi.org/10.1042/BST0350881>10.1042/BST0350881</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR5</td><td>BibArticle</td><td>Van Veldhoven PP. Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism. J Lipid Res. 2010;51:2863&#8211;95.</td><td><a href=http://dx.doi.org/10.1194/jlr.R005959>10.1194/jlr.R005959</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Krause C, Rosewich H, Gartner J. Rational diagnostic strategy for Zellweger syndrome spectrum patients. Eur J Hum Genet. 2009;17:741&#8211;8.</td><td><a href=http://dx.doi.org/10.1038/ejhg.2008.252>10.1038/ejhg.2008.252</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Wierzbicki AS. Clinical significance of oxidation from phytol to phytanic acid in man. Mol Genet Metab. 2004;83:347.</td><td><a href=http://dx.doi.org/10.1016/j.ymgme.2004.06.011>10.1016/j.ymgme.2004.06.011</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Wanders RJ, Jansen GA, Skjeldal OH. Refsum disease, peroxisomes and phytanic acid oxidation: a review. J Neuropathol Exp Neurol. 2001;60:1021&#8211;31.</td><td><a href=http://dx.doi.org/10.1093/jnen/60.11.1021>10.1093/jnen/60.11.1021</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Schonfeld P, Wojtczak L. Fatty acids decrease mitochondrial generation of reactive oxygen species at the reverse electron transport but increase it at the forward transport. Biochim Biophys Acta. 2007;1767:1032&#8211;40.</td><td><a href=http://dx.doi.org/10.1016/j.bbabio.2007.04.005>10.1016/j.bbabio.2007.04.005</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR10</td><td>BibArticle</td><td>Busanello EN, Zanatta A, Tonin AM, Viegas CM, Vargas CR, Leipnitz G, Ribeiro CA, Wajner M. Marked inhibition of Na+, K (+)-ATPase activity and the respiratory chain by phytanic acid in cerebellum from young rats: possible underlying mechanisms of cerebellar ataxia in Refsum disease. J Bioenerg Biomembr. 2013;45:137&#8211;44.</td><td><a href=http://dx.doi.org/10.1007/s10863-012-9491-7>10.1007/s10863-012-9491-7</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR11</td><td>BibArticle</td><td>Grygiel_Gorniak B. Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications&#8211;a review. Nutr J. 2014;13:17.</td><td><a href=http://dx.doi.org/10.1186/1475-2891-13-17>10.1186/1475-2891-13-17</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR12</td><td>BibArticle</td><td>Idel S, Ellinghaus P, Wolfrum C, Nofer JR, Gloerich J, Assmann G, Spener F, Seedorf U. Branched chain fatty acids induce nitric oxide-dependent apoptosis in vascular smooth muscle cells. J Biol Chem. 2002;277:49319&#8211;25.</td><td><a href=http://dx.doi.org/10.1074/jbc.M204639200>10.1074/jbc.M204639200</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Van Heerebeek L, Meischi C, Stooker W, Meijer CJ, Niessen HW, Ross D. NADPH oxidase (s): new source (s) of reactive oxygen species in the vascular system. J Clin Pathol. 2002;55:561&#8211;8.</td><td><a href=http://dx.doi.org/10.1136/jcp.55.8.561>10.1136/jcp.55.8.561</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR14</td><td>BibArticle</td><td>Bengtsson SH, Gulluyan LM, Dusting GJ, Drummond GR. Novel isoforms of NADPH oxidase in vascular physiology and pathophysiology. Clin Exp Pharmacol Physiol. 2003;30:860&#8211;6.</td><td><a href=http://dx.doi.org/10.1046/j.1440-1681.2003.03929.x>10.1046/j.1440-1681.2003.03929.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR15</td><td>BibArticle</td><td>Guichard C, Moreau R, Pessayre D, Epperson TK, Krause KH. NOX family NADPH oxidases in liver and in pancreatic islets: a role in the metabolic syndrome and diabetes? Biochem Soc Trans. 2008;36:920&#8211;9.</td><td><a href=http://dx.doi.org/10.1042/BST0360920>10.1042/BST0360920</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR16</td><td>BibArticle</td><td>Sedeek M, Hebert RL, Kennedy CR, Burns KD, Touyz RM. Molecular mechanisms of hypertension: role of Nox family NADPH oxidases. Curr Opin Nephrol Hyperten. 2009;18:122&#8211;7.</td><td><a href=http://dx.doi.org/10.1097/MNH.0b013e32832923c3>10.1097/MNH.0b013e32832923c3</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR17</td><td>BibArticle</td><td>Violi F, Basili S, Nigro C, Pignatelli P. Role of NADPH oxidase in atherosclerosis. Future Cardiol. 2009;5:83&#8211;92.</td><td><a href=http://dx.doi.org/10.2217/14796678.5.1.83>10.2217/14796678.5.1.83</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR18</td><td>BibArticle</td><td>Barry-Lane PA, Patterson C, van der Merwe M, Hu Z, Holland SM, Yeh ET, Runge MS. p47phox is required for atherosclerotic lesion progression in ApoE (&#8211;/&#8211;) mice. J Clin Invest. 2001;108:1513&#8211;22.</td><td><a href=http://dx.doi.org/10.1172/JCI200111927>10.1172/JCI200111927</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR19</td><td>BibArticle</td><td>Weaver M, Liu J, Pimentel D, Reddy DJ, Harding P, Peterson EL, Pagano PJ. Adventitial delivery of dominant-negative p67phox attenuates neointimal hyperplasia of the rat carotic artery. Am J Physiol Heart Circ Physiol. 2006;290:H1933&#8211;41.</td><td><a href=http://dx.doi.org/10.1152/ajpheart.00690.2005>10.1152/ajpheart.00690.2005</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Herrera M, Silva GB, Garvin JL. Angiotensin II stimulates thicj ascending limb superoxide production via protein kinase c (&#945;)-dependent NADPH oxidase activation. J Biol Chem. 2010;285:21323&#8211;8.</td><td><a href=http://dx.doi.org/10.1074/jbc.M110.109157>10.1074/jbc.M110.109157</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR21</td><td>BibArticle</td><td>Morgan MJ, Liu ZG. Reactive oxygen species in TNF alpha-induced signaling and cell death. Mol Cells. 2010;30:1&#8211;12.</td><td><a href=http://dx.doi.org/10.1007/s10059-010-0105-0>10.1007/s10059-010-0105-0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Kreuzer J, Viedt C, Brandes RP, Seeger F, Rosemkranzz AS, Sauer H, Babich A, Nurnberg B, Kather H, Krieger-Brauer HI. Platelet-derived growth factor activates production of reactive oxygen species by NAD (P) H oxidase in smooth muscle cells through Gi1,2. FASEB J. 2003;17:38&#8211;40.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1096/fj.01-1036fje>10.1096/fj.01-1036fje</a></td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR23</td><td>BibArticle</td><td>Lloyd MD, Darley DJ, Wierzbicki AS, Threadgill MD. Alpha-methylacyl-CoA racemase.an &#8220;obscure&#8217; metabolic enzyme takes center stage. FEBS J. 2008;275:1089&#8211;102.</td><td><a href=http://dx.doi.org/10.1111/j.1742-4658.2008.06290.x>10.1111/j.1742-4658.2008.06290.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR24</td><td>BibArticle</td><td>Roy K, Wu Y, Meitzler JL, Juhasz A, Liu H, Jiang G, Lu J, Antony S, Doroshow JH. NADPH oxidases and cancer. Clin Sci. 2015;128:863&#8211;75.</td><td><a href=http://dx.doi.org/10.1042/CS20140542>10.1042/CS20140542</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR25</td><td>BibArticle</td><td>Helfinger V, Henke N, Harenkamp S, Walter M, Epah J, Penski C, Mittelbron M, Schroder K. The NADPH Oxidase Nox4 mediated tumor angiogenesis. Acta Physiol. 2016;216:435&#8211;46.</td><td><a href=http://dx.doi.org/10.1111/apha.12625>10.1111/apha.12625</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR26</td><td>BibArticle</td><td>Appert-Colin A, Hubert P, Cremel G, Bennasroune A. Role of ErbB receptors in cancer Cell Migration and Invasion. Frontiers Pharmacol. 2015;6:1&#8211;10.</td><td><a href=http://dx.doi.org/10.3389/fphar.2015.00283>10.3389/fphar.2015.00283</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR27</td><td>BibArticle</td><td>Schreier B, Gekle M, Grossman C. Role of epidermal growth factor receptor in vascular structure and function. Curr Opin Nephrol Hypertens. 2014;23:113&#8211;21.</td><td><a href=http://dx.doi.org/10.1097/01.mnh.0000441152.62943.29>10.1097/01.mnh.0000441152.62943.29</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR28</td><td>BibArticle</td><td>Kota R, Gundet S, Gullipalli M, Linga VG, Maddali LS, Digumarti R. Prevalence and outcome of epidermal growth factor mutations in non-squamous non-small cell lung cancer patients. Lung India. 2015;32:561&#8211;5.</td><td><a href=http://dx.doi.org/10.4103/0970-2113.168099>10.4103/0970-2113.168099</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR29</td><td>BibArticle</td><td>Dhaunsi GS, Hassid A. Atrial and C-type natriuretic peptides amplify growth factor activity in primary aortic smooth muscle cells. Cardiovasc Res. 1996;31:37&#8211;47.</td><td><a href=http://dx.doi.org/10.1016/S0008-6363(95)00148-4>10.1016/S0008-6363(95)00148-4</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR30</td><td>BibArticle</td><td>Jalil JE, Perez A, Ocaranza MP, Bargetto J, Galaz A, Lavandero S. Increased aortic NADPH oxidase activity in rats with genetically high angiotensin-converting enzyme levels. Hypertension. 2005;46:1362&#8211;7.</td><td><a href=http://dx.doi.org/10.1161/01.HYP.0000188980.57312.63>10.1161/01.HYP.0000188980.57312.63</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR31</td><td>BibArticle</td><td>Akhtar S, Yousif MH, Chandrasekhar B, Benter IF. Activation of EGFR/ERBB2 via pathways involving ERK1/2, P38 MAPK, AKT and FOXO enhances recovery of diabetic hearts from ischemia-reperfusion injury. PLoS One. 2012;7(6), e39066.</td><td><a href=http://dx.doi.org/10.1371/journal.pone.0039066>10.1371/journal.pone.0039066</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR32</td><td>BibArticle</td><td>Hirafuji M, Machida T, Tsunida M, Miyamoto A, Minami I. Docosahexaenoic acid potentiates interleukin-1 beta induction of nitric oxide synthase through mechanism involving p44/42 MAPK activation in rat vascular smooth muscle cells. Br J Pharmacol. 2002;136:613&#8211;9.</td><td><a href=http://dx.doi.org/10.1038/sj.bjp.0704768>10.1038/sj.bjp.0704768</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR33</td><td>BibArticle</td><td>Naseem KM. The role of nitric oxide in cardiovascular diseases. Mol Aspects Med. 2005;26:33&#8211;65.</td><td><a href=http://dx.doi.org/10.1016/j.mam.2004.09.003>10.1016/j.mam.2004.09.003</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR34</td><td>BibArticle</td><td>Bian K, Doursout MF, Murad F. Vascular system: role of nitric oxide in cardiovascular diseases. J Clin Hypertens. 2008;10:304&#8211;10.</td><td><a href=http://dx.doi.org/10.1111/j.1751-7176.2008.06632.x>10.1111/j.1751-7176.2008.06632.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR35</td><td>BibArticle</td><td>Ginnan R, Guikema BJ, Halligan KE, Singer HA, Jourd&#8217;heuil D. Regulation of smooth muscle by inducible nitric oxide synthase and NADPH oxidase in vascular proliferative diseases. Free Radic Biol Med. 2008;44:1232&#8211;45.</td><td><a href=http://dx.doi.org/10.1016/j.freeradbiomed.2007.12.025>10.1016/j.freeradbiomed.2007.12.025</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR36</td><td>BibArticle</td><td>Nickenig G, Baudler S, Muller C, Werner C, Werner N, Welzel H, Strehlow K, Bohm M. Redox-sensitive vascular smooth muscle cell proliferation is mediated by GKLF and Id3 in vitro and in vivo. FASEB J. 2002;16:1077&#8211;86.</td><td><a href=http://dx.doi.org/10.1096/fj.01-0570com>10.1096/fj.01-0570com</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr></table>